Hubbry Logo
BiodermaBiodermaMain
Open search
Bioderma
Community hub
Bioderma
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Bioderma
Bioderma
from Wikipedia

Bioderma Laboratories is a privately owned French pharmaceutical company that specialises in medication for dermatological and hair/scalp conditions, as well as for Pediatry and cell regeneration.[4] It was founded in 1977, in Aix en Provence, where its headquarters still reside. However, in 2001, the company opened its first specialised biometrology laboratory for skincare research and development in Lyon. Its primary business sector is Dermatology, with products such as ABCDerm, Atoderm, Cicabio, Créaline, Hydrabio, Matriciane, Matricium, Sébium, White Objective, secure (skin care), Nodé (hair care) and Photoderm (sun care).[citation needed]

Key Information

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia
from Grokipedia
Bioderma is a French dermo-cosmetic brand specializing in skincare products designed to respect and restore the skin's natural ecosystem, founded in 1977 by pharmacist-biologist Jean-Noël Thorel as the inaugural line of the NAOS group. Headquartered in Aix-en-Provence, France, Bioderma operates under the pioneering philosophy of ecobiology, which emphasizes acting in harmony with the skin's biological mechanisms and environmental interactions to promote long-term health rather than merely treating symptoms. This approach, developed through NAOS's CEREDAP Research Center established in 1977, has led to over 80 patent families and collaborations with institutions like INSERM and CNRS, focusing on innovations such as the 1995 invention of micellar water technology in its flagship Sensibio H2O product—a gentle, no-rinse cleanser that mimics the skin's natural lipid structure for makeup removal and sensitive skin care. The brand's product portfolio includes targeted ranges for diverse concerns, such as Sensibio for sensitive and reactive (featuring foaming gels, micellar waters, and soothing creams), Sebium for oily and acne-prone (with purifying cleansers and mattifying moisturizers), Atoderm for dry to atopic (offering intensive balms, oils, and shower gels), and additional lines like Pigmentbio for pigmentation issues and Photoderm for sun . All formulations are co-developed with dermatologists, rigorously tested for tolerance (involving 450 formulas and 650 ingredients annually), and produced at a single site in to ensure quality and traceability, with full ingredient transparency provided via the AskNAOS platform. Present in over 130 countries with approximately 3,500 employees worldwide, Bioderma upholds NAOS's commitments to , including protection (particularly aquatic environments) and ethical practices that prioritize the living world's balance. Tools like the SkinObserver app further personalize routines by analyzing skin conditions, reinforcing the brand's mission to make advanced accessible while preserving skin's inherent vitality.

History

Founding and early development

Bioderma was founded in 1977 by Jean-Noël Thorel, a French and , in , , as part of the newly established NAOS group. Thorel, who had begun his career working in a before advancing to a directorial role in the , sought independence to pursue innovative skincare solutions. Starting with modest resources—a warehouse in near and an initial investment of 2,000 francs (approximately 300 euros)—he aimed to revolutionize by integrating biological principles into product development. Thorel's motivation stemmed from his expertise in and , driving him to create "active cosmetics" that respected the skin's natural rather than merely masking surface issues. Influenced by a humanist perspective, including inspirations from literature like , he collaborated with scientists, dermatologists, and pharmacists to formulate products that supported the skin's inherent functions. This approach marked a departure from conventional of the era, which were often limited to basic hygiene, emphasizing instead biological harmony to enhance skin health without disruption. In the same year, Bioderma launched its first product, Nodé , developed through the newly created Research Center CEREDAP (Centre d'Etudes et de Recherches en Esthétique et Dermatologie Appliquée). This innovation introduced the market's first non-detergent-based , named from "Non-DEtergence" to highlight its gentle formula, which preserved the hair's hydrolipidic film and respected the scalp's biological balance. Designed for , it prioritized non-irritating ingredients to minimize disruption, establishing Bioderma's early focus on dermatological formulations tailored to the through small-scale operations.

Key milestones and expansions

In 1995, Bioderma revolutionized skincare with the invention of Sensibio H2O, the first micellar water, developed by founder Jean-Noël Thorel as a gentle cleansing solution for sensitive that mimics the skin's natural hydrolipidic film. This innovation, patented under Bioderma's technology, established a new category in dermo-cosmetics and became a global bestseller recommended by dermatologists. Bioderma began its international expansion in 2001 by opening its first affiliate in , marking the start of growth beyond and leading to presence in over 100 countries by the mid-2010s. The company further extended into through humanitarian missions starting in 2009 and partnerships, such as in via in 2012, and entered the market with dedicated distribution channels by the early , including retail expansion at Target in 2022. In 2016, Bioderma integrated with sister brands Institut Esthederm and Etat Pur under the NAOS group, enhancing synergies in research and while maintaining independent brand identities. This restructuring supported sustained growth, with Bioderma achieving €609 million in revenue in 2022 and employing part of NAOS's 3,500 global staff. Recent advancements include the 2024 launch of Skin Observer, an AI-driven tool developed with Haut.AI for personalized skin analysis and ecobiological recommendations, initially rolled out in with global expansion. In 2025, Bioderma celebrated the 30th anniversary of Sensibio H2O, introduced a refreshed visual identity emphasizing dermatological innovation, and acquired a new production facility in for enhanced R&D capacity.

Products

Product lines by skin concern

Bioderma organizes its product lines according to specific skin concerns, targeting various dermatological needs with formulations designed to respect the 's natural . These ranges address common issues such as sensitivity, oiliness, dryness, , sun exposure, pediatric care, repair, and pigmentation irregularities, offering tailored solutions like cleansers, moisturizers, and treatments. The Sensibio line is formulated for sensitive and reactive , providing gentle cleansing and soothing care to reduce redness and discomfort while reinforcing the barrier. It includes micellar waters, foaming gels, serums, and creams that hydrate without irritation, suitable for daily use across all skin tones. For oily and acne-prone , the Sébium line focuses on purification and mattification, helping to regulate sebum production and minimize imperfections in combination to oily types. Key offerings encompass foaming cleansers, micellar solutions, and lightweight moisturizers that maintain balance without drying the . The Atoderm range targets dry to atopic , delivering intensive moisturization and barrier repair to alleviate tightness and prevent flare-ups in sensitive, very dry conditions. It features the Atoderm Shower Gel, a highly rated gentle, soap-free, moisturizing cleanser designed for normal to dry and sensitive skin that cleanses without stripping natural oils, leaving skin soft, hydrated, and soothed, often reducing dryness or itching. User reviews praise its light scent, suitability for eczema-prone or family use (including children), and long-lasting bottle, with an average rating of 4.6/5 from over 11,000 Amazon reviews; minor drawbacks include higher price and less lather compared to conventional gels. The range also includes shower oils, such as the Atoderm Shower Oil, a nourishing oil-based cleanser for very dry or atopic skin that provides 24-hour relief from tightness, restores lipids without leaving residue, along with balms and ultra-creams for face and body, promoting long-lasting comfort and suppleness. Hydrabio addresses dehydrated concerns, restoring hydration and plumpness to combat dullness and tightness in sensitive types, adaptable to dry, oily, or skins. The line includes foaming cleansers, hydrating serums, and enveloping creams that support the skin's natural moisture retention. In September 2025, the Hydrabio line was relaunched with updated formulations offering up to 72 hours of hydration. Photoderm provides broad-spectrum sun protection for all types, emphasizing UV defense with added hydration and minimal to prevent sun-induced . It offers fluids, sprays, and creams in various SPF levels, suitable for face and body across different sensitivities. The ABCDerm line is dedicated to pediatric care for babies and young children, featuring , gentle products that cleanse and nourish fragile without disrupting its natural balance. It includes foaming gels, micellar waters, and cold creams formulated under strict dermatological safety standards. Cicabio specializes in wound repair and soothing for damaged or irritated , accelerating of non-oozing lesions on face and body while restoring the . Products like repairing creams provide ultra-soothing action for weakened areas post-aggression. Finally, Pigmentbio targets correction, reducing dark spots such as or age spots on sensitive through brightening and corrective care. The range includes daily creams and targeted treatments that even out tone without causing irritation.

Notable innovations and flagship products

Bioderma's Sensibio H2O Micellar Water, launched in 1995, represents a pioneering advancement in gentle cleansing for sensitive skin. This product pioneered modern micellar water technology for skincare, featuring patented micellar technology that utilizes micelles—tiny surfactant spheres—to mimic the skin's natural lipids and cleanse without disrupting the hydrolipidic film, allowing effective makeup removal and impurity elimination without the need for rinsing. According to the company, one bottle is sold every two seconds globally as of 2025, establishing it as a cornerstone of Bioderma's portfolio for sensitive skin care. To mark its 30th anniversary, a limited-edition bottle was released in collaboration with Victoria Beckham. Another flagship innovation is Matricium, a sterile, preservative-free formulated as a serum containing a 100% biomimetic complex of over 50 ingredients naturally present in the , such as , vitamins, minerals, and , to recreate an optimal cellular environment for tissue regeneration. Designed for use in clinical and post-procedure settings, it promotes repair by stimulating cell renewal, enhancing cohesion, and supporting recovery from superficial lesions caused by dermatological treatments like lasers or peels, without acting as a traditional cosmetic or drug. Central to many Bioderma formulations is the patented D.A.F. Complex (Dermatological Advanced Formulation), a natural, biology-derived soothing agent that strengthens the 's tolerance threshold by targeting factors that induce reactivity, such as environmental stressors, thereby reducing sensitivity across various product lines for different types. This innovation biologically enhances the 's innate defenses, making it less prone to and . In sun protection, Bioderma's Photoderm range incorporates the Cellular Bioprotection patent, which combines advanced UVA/UVB filters with antioxidants like mannitol and xylitol to activate the skin's natural repair mechanisms and protect cellular DNA from UV-induced damage, offering comprehensive internal and external defense beyond traditional screening. This technology ensures broad-spectrum efficacy while maintaining skin tolerance, particularly for sensitive or reactive complexions. For acne management, Sébium Global exemplifies Bioderma's targeted approach, integrating the patented Fluidactiv technology—a complex of sebum-oxidizing agents and micro-exfoliants—to biologically regulate sebum quality, prevent pore clogging, and address the root causes of blemishes like excess oil and bacterial proliferation, resulting in reduced and clearer . This intensive purifying care is formulated for severe -prone , combining and keratolytic actions for visible improvement in imperfections.

Scientific approach

Ecobiology philosophy

Ecobiology is a scientific approach pioneered by NAOS, the parent company of Bioderma, in 1977, which views the skin as a living, ever-evolving that interacts with its internal and external environments. This philosophy emphasizes preserving the skin's natural resources and mechanisms rather than overriding them, addressing the root causes of imbalances to support long-term skin health. At its core, Ecobiology rests on four key principles: considering the as an , interacting with its natural mechanisms, acting on both causes and consequences of disruptions, and being driven by biomimetism to mimic the 's biological processes. It promotes respect for the 's , including the diverse community of cells, microorganisms, and environmental factors that maintain balance, while enabling tailored to each individual's unique biology. Additionally, it incorporates by prioritizing formulations that minimize disruption to the 's and broader environmental impact. Unlike conventional skincare, which often focuses on surface-level symptom treatment with potentially aggressive chemicals, Ecobiology differentiates by acting deeply within the skin to relaunch its self-regulation capabilities, using biomimetic ingredients that align with the skin's for a therapeutic-cosmetic . This approach avoids overtreatment and instead strengthens the skin's adaptive defenses, such as enhancing and preserving microbiome diversity, as seen in formulations designed to support natural regeneration without altering the .

Research and development facilities

Bioderma's research and development infrastructure includes the CEREDAP Research Center in , , established in 1977 as the foundational facility for NAOS, dedicated to advancing ecobiology and skincare innovations through biological research. This center has driven key developments, including over 80 patent families in skin biology. Additionally, a specialized biometrology laboratory was established in , , in 2001, employing non-invasive techniques to evaluate and support evidence-based formulations focused on skin barrier integrity and environmental responses. The company's R&D efforts involve close collaborations with dermatologists, biologists, and clinical partners, fostering a co-development process that emphasizes rigorous testing for efficacy and safety. In the decade leading up to 2023, Bioderma conducted more than 70 clinical trials involving approximately 9,000 patients, ensuring products meet dermatological standards while respecting skin biology. This network, guided by ecobiology principles, integrates insights from leading experts to refine formulations that support the skin's natural ecosystem. To promote ingredient transparency, Bioderma utilizes the AskNAOS digital platform, developed by its parent company NAOS, which decodes product formulas for consumers. This tool explains the nature, origin, and biological role of each , emphasizing compatibility with physiology and educating users on ecobiology-aligned choices. By providing access to details on over 650 across 450 formulas, AskNAOS enhances trust and informed skincare decisions. Bioderma invests in sustainability-focused R&D, prioritizing eco-designed and microbiome-compatible preservatives to minimize environmental impact. Initiatives include eliminating single-use elements like and spatulas, sourcing certified sustainable , and selecting marine-friendly active ingredients. Recent studies from NAOS's research confirm that certain leave-on products preserve microbiome diversity without disruption, aligning with microbiome-friendly preservation strategies. The patent portfolio includes over 80 families of innovations in biology, including micellar technology for gentle cleansing and cellular bioprotection for DNA defense against aggressors.

Corporate structure

Ownership and leadership

Bioderma operates as a wholly owned of the NAOS Group, established as its upon Bioderma's founding in 1977, and NAOS has maintained its status as a private entity with no public stock listing as of 2025. NAOS itself is fully owned by the Jean-Noël Thorel Foundation, a non-profit endowment fund created in 2014 and endowed with 100% of NAOS's assets in 2018 to ensure long-term independence and value sharing. The company's leadership is anchored by Jean-Noël Thorel, its founder and current president, who continues to shape its strategic direction as a pharmacist-biologist pioneering the integration of biology into dermatological care. In October 2025, NAOS announced the appointment of Frédéric Ennabli, former head of Pierre Fabre Dermo-Cosmetics, as chair of its executive board, effective January 2026, to drive innovation and international expansion. Governance at NAOS, and by extension Bioderma, follows a foundation-based model that separates equity ownership from operational decision-making, prioritizing ethical practices, sustainable innovation, and alignment with the Ecobiology philosophy to foster and ecosystem balance. This structure supports a of approximately 3,500 employees globally, emphasizing expertise in , , and related scientific fields to advance purpose-driven skincare solutions.

Global operations and market presence

Bioderma is headquartered in , , where its parent company NAOS maintains the primary manufacturing facilities at NAOS Les Laboratoires. All Bioderma products are produced at this single site in , emphasizing European-based operations and . This centralized manufacturing approach supports the brand's commitment to consistent formulation standards across its global . In September 2025, NAOS acquired a new production plant dedicated to . The brand has expanded to over 130 countries worldwide, establishing a robust international footprint. It maintains a strong presence in as its core market, while also achieving significant penetration in through dedicated U.S. operations, —particularly where it captured 5.6% of the cosmetics market in 2024—and via targeted expansion strategies. This reach reflects steady growth in the dermo-cosmetics sector. In November 2025, NAOS partnered with DFP World to extend Bioderma's distribution in the African travel retail market. Distribution occurs primarily through professional channels such as pharmacies and dermatologist offices, aligning with its dermatological focus, alongside select online retailers and beauty chains. In the U.S., partnerships with retailers like enable broader accessibility, offering products both in-store and online with free shipping options. This selective model prioritizes expert recommendations and controlled availability to maintain product integrity. As a leader in the dermo-cosmetics market, Bioderma's commercial success is driven by innovative offerings like its micellar water, which sells one bottle every second and remains the bestselling in . The brand's has shown consistent growth, fueled by global demand for its ecobiology-based solutions.

References

Add your contribution
Related Hubs
User Avatar
No comments yet.